<p><img src="https://imageproxy.pbkrs.com/https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-6835671d9b89fd5016ae3a8a3e6abfcb-resized.jpeg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-6835671d9b89fd5016ae3a8a3e6abfcb-resized.jpeg"/></p>
<p>医疗供应和物流公司欧麦斯 - 麦能医疗将在本周一市场开盘前公布财报。以下是您需要了解的内容。</p>
<p>欧麦斯 - 麦能医疗上个季度的收入未能达到分析师的预期，差距为 1.6%，报告收入为 26.3 亿美元，同比持平。对于公司来说，这是一个较慢的季度，略微低于分析师对全年每股收益的指导预期。</p>
<p>在财报发布前，欧麦斯 - 麦能医疗是买入还是卖出？请阅读我们的完整分析，免费提供。</p>
<p>本季度，分析师预计欧麦斯 - 麦能医疗的收入将同比增长 2.1%，达到 27.3 亿美元，低于去年同期 4.2% 的增长。调整后的每股收益预计为 0.28 美元。</p>
<p><img src="https://imageproxy.pbkrs.com/https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-f42bea40bc1a92e9eee9d81b7822be61-resized.jpeg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-f42bea40bc1a92e9eee9d81b7822be61-resized.jpeg"/></p>
<p>在过去 30 天内，覆盖该公司的分析师大多数重新确认了他们的预期，表明他们预计公司在财报发布前将保持现状。欧麦斯 - 麦能医疗在过去两年中三次未能达到华尔街的收入预期。</p>
<p>观察欧麦斯 - 麦能医疗在医疗服务和提供者领域的同行，一些公司已经公布了第二季度的业绩，给我们提供了一些预期的线索。麦克森的收入同比增长 23.4%，超出分析师预期 1.4%；CVS Health 的收入增长 8.4%，超出预期 5.1%。麦克森在业绩公布后股价下跌 1.1%，而 CVS Health 的股价保持不变。</p>
<p>请在这里阅读我们对麦克森业绩的完整分析，以及对 CVS Health 业绩的分析。</p>
<p>关于可能的关税和企业税调整的辩论引发了对 2025 年经济稳定性的质疑。尽管一些医疗服务和提供者股票在这种波动的环境中表现良好，但整体表现不佳，过去一个月平均股价下跌 5.1%。欧麦斯 - 麦能医疗在同一时期下跌了 20.8%，并以分析师平均目标价 9.50 美元（相比当前股价 6.43 美元）进入财报发布。</p>
<p>当一家公司拥有多余的现金时，回购自己的股票是一个明智的选择——只要价格合适。幸运的是，我们发现了一只低价股票，现金流充裕且正在回购股票。</p>
<p>StockStory 正在扩张，并招聘股票分析师和市场营销职位。您是否是一个对市场和人工智能充满热情的 0 到 1 建设者？请查看开放职位。</p>

欧麦斯-麦能医疗

<p>欧麦斯 - 麦能医疗（Owens & Minor，OMI）将在明天市场开盘前公布财报。上个季度，该公司未能达到收入预期，收入为 26.3 亿美元，低于预期 1.6%。分析师预计本季度收入将增长 2.1%，达到 27.3 亿美元，调整后的每股收益为 0.28 美元。在过去两年中，欧麦斯 - 麦能医疗已经三次未能达到收入预期。该股在过去一个月下跌了 20.8%，分析师的平均目标价为 9.50 美元，而当前股价为 6.43 美元</p>

<p><img src="https://imageproxy.pbkrs.com/https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-6835671d9b89fd5016ae3a8a3e6abfcb-resized.jpeg" alt="" original-src="https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-6835671d9b89fd5016ae3a8a3e6abfcb-resized.jpeg"/></p>
<p>Medical supply and logistics company Owens &amp; Minor  will be announcing earnings results this Monday before market hours. Here’s what you need to know.</p>
<div class="lb-trans"><p>医疗供应和物流公司欧麦斯 - 麦能医疗将在本周一市场开盘前公布财报。以下是您需要了解的内容。</p>
</div><p>Owens &amp; Minor missed analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $2.63 billion, flat year on year. It was a slower quarter for the company, with a slight miss of analysts’ full-year EPS guidance estimates.</p>
<div class="lb-trans"><p>欧麦斯 - 麦能医疗上个季度的收入未能达到分析师的预期，差距为 1.6%，报告收入为 26.3 亿美元，同比持平。对于公司来说，这是一个较慢的季度，略微低于分析师对全年每股收益的指导预期。</p>
</div><p>Is Owens &amp; Minor a buy or sell going into earnings? Read our full analysis here, it’s free.</p>
<div class="lb-trans"><p>在财报发布前，欧麦斯 - 麦能医疗是买入还是卖出？请阅读我们的完整分析，免费提供。</p>
</div><p>This quarter, analysts are expecting Owens &amp; Minor’s revenue to grow 2.1% year on year to $2.73 billion, slowing from the 4.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.28 per share.</p>
<div class="lb-trans"><p>本季度，分析师预计欧麦斯 - 麦能医疗的收入将同比增长 2.1%，达到 27.3 亿美元，低于去年同期 4.2% 的增长。调整后的每股收益预计为 0.28 美元。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-f42bea40bc1a92e9eee9d81b7822be61-resized.jpeg" alt="" original-src="https://s3.tradingview.com/news/image/stockstory:6a86981c4094b-f42bea40bc1a92e9eee9d81b7822be61-resized.jpeg"/></p>
<p>The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Owens &amp; Minor has missed Wall Street’s revenue estimates three times over the last two years.</p>
<div class="lb-trans"><p>在过去 30 天内，覆盖该公司的分析师大多数重新确认了他们的预期，表明他们预计公司在财报发布前将保持现状。欧麦斯 - 麦能医疗在过去两年中三次未能达到华尔街的收入预期。</p>
</div><p>Looking at Owens &amp; Minor’s peers in the healthcare providers &amp; services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. McKesson delivered year-on-year revenue growth of 23.4%, beating analysts’ expectations by 1.4%, and CVS Health reported revenues up 8.4%, topping estimates by 5.1%. McKesson traded down 1.1% following the results while CVS Health’s stock price was unchanged.</p>
<div class="lb-trans"><p>观察欧麦斯 - 麦能医疗在医疗服务和提供者领域的同行，一些公司已经公布了第二季度的业绩，给我们提供了一些预期的线索。麦克森的收入同比增长 23.4%，超出分析师预期 1.4%；CVS Health 的收入增长 8.4%，超出预期 5.1%。麦克森在业绩公布后股价下跌 1.1%，而 CVS Health 的股价保持不变。</p>
</div><p>Read our full analysis of McKesson’s results here and CVS Health’s results here.</p>
<div class="lb-trans"><p>请在这里阅读我们对麦克森业绩的完整分析，以及对 CVS Health 业绩的分析。</p>
</div><p>Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers &amp; services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.1% on average over the last month. Owens &amp; Minor is down 20.8% during the same time and is heading into earnings with an average analyst price target of $9.50 (compared to the current share price of $6.43).</p>
<div class="lb-trans"><p>关于可能的关税和企业税调整的辩论引发了对 2025 年经济稳定性的质疑。尽管一些医疗服务和提供者股票在这种波动的环境中表现良好，但整体表现不佳，过去一个月平均股价下跌 5.1%。欧麦斯 - 麦能医疗在同一时期下跌了 20.8%，并以分析师平均目标价 9.50 美元（相比当前股价 6.43 美元）进入财报发布。</p>
</div><p>When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares.</p>
<div class="lb-trans"><p>当一家公司拥有多余的现金时，回购自己的股票是一个明智的选择——只要价格合适。幸运的是，我们发现了一只低价股票，现金流充裕且正在回购股票。</p>
</div><p>StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.</p>
<div class="lb-trans"><p>StockStory 正在扩张，并招聘股票分析师和市场营销职位。您是否是一个对市场和人工智能充满热情的 0 到 1 建设者？请查看开放职位。</p>
</div>

欧麦斯 - 麦能医疗（OMI）将在明天公布财报：有哪些值得期待的内容